Manufacture

Anna Codina from Bruker BioSpin discusses the Biosecure Act and how outsourcing could be affected.

How whole genome sequencing is being used to understand the bacterium that causes syphilis – and what it means for vaccine development.

The Alliance for RTU has been founded to accelerate and improve manufacturing quality, consistency, and regulatory efficiency.

Why the traditional model of drug development is no longer fit for purpose.

Sitting Down With… Lars Petersen, President and CEO, FUJIFILM Diosynth Biotechnologies

Continuous processing for small molecule products has been a hot topic for years, but where does the industry stand with it today?

From developments in cell culture media to enhancing the potency of monoclonal antibodies – check out our free eBook.

The analytical complexities that come with oligonucleotide manufacturing are difficult, but not impossible.

With so many CDMOs to choose from, what should you consider before picking your partner? Here’s some advice from Vetter.

Ever wondered what the distant future of pharma and healthcare looks like? A group of industry experts offer their sage predictions.